Ó³»­´«Ã½

A common prostate cancer mutation retargets an epigenetic complex to force prostate cells down a malignant path, creating a possible therapeutic opportunity in the process.

Clones and blood cancer, babies' microbiomes, a step toward enhancer prediction, and more.

This week: a new angle on an old oncogene, rare variants in common disorders, and molecular hijacking fuels a rare cancer.

By merging cancer functional genetic data with information on protein interactions, scientists can explore protein complexes at massive scale.

In defining the cellular context of diffuse midline gliomas, researchers find the cells fueling their growth and suggest a potential approach to treating them: forcing their cells to be more mature.

DroNc-Seq — a technology that merges single-nucleus RNA sequencing with microfluidics — brings new scale to gene expression studies in complex tissues.